OK
The Universal Selection Source:
Coatings Ingredients
Industry News

Dow & OPXBio to Discuss Progress & Challenges of Bio Acrylic Acid at the Biobased Chemicals Conf

Published on 2012-07-26. Author : SpecialChem

The Dow Chemical Company & OPX Biotechnologies to give a Joint Presentation at the 3rd Biobased Chemicals: Commercialization & Partnering Conference (Sep 13-14, 2012 in San Francisco, CA).

The Dow Chemical Company & OPX Biotechnologies will give a Joint Presentation entitled "Bio Acrylic Acid Commercialization Progress and Challenges" at the 3rd Biobased Chemicals: Commercialization & Partnering Conference on Sep 13-14, 2012 in San Francisco, CA.

In March 2011, The Dow Chemical Company and OPX Biotechnologies, Inc. (OPXBIO) signed a joint development agreement to prove the technical and economic viability of an industrial-scale process to produce acrylic acid using a fermentable sugar (such as corn and/or cane sugar) feedstock with equal performance qualities as petroleum-based acrylic acid, creating a renewable bio-acrylic option for the market. The global petroleum-based acrylic acid market is $8 billion and growing 3 to 4 percent per year. Acrylic acid is a key chemical building block used in a wide range of consumer goods including paints, adhesives, diapers and detergents. Since entering into their joint collaboration, Dow and OPXBIO have made significant progress on technology scale up and commercial development of the bio-acrylic acid process. This presentation will focus on the progress made and current state of commercialization of the technology including discussion on the unique challenges remaining.

Presenting at the 3rd Biobased Chemicals Conference will be top executive speakers from the following companies: Amyris, BASF, Bayer MaterialScience LLC., CBiRC, Ceres, Inc., Chemtex, Codexis, DSM, DSM Venturing, Flagship Ventures, Genomatica, Gevo, LanzaTech, LS 9, Lux Research, Myriant Corporation, OPX Biotechnologies, Proterro, Segetis, Solazyme, The Dow Chemical Company, USDA, Agricultural Research Service, Western Regional Research Center, USDA, Environmental Managment Division (EMD), Verdezyne, Virdia, Virent, ZeaChem and many more!

About Dow

Dow combines the power of science and technology to passionately innovate what is essential to human progress. The Company connects chemistry and innovation with the principles of sustainability to help address many of the world's most challenging problems such as the need for clean water, renewable energy generation and conservation, and increasing agricultural productivity. Dow's diversified industry-leading portfolio of specialty chemical, advanced materials, agrosciences and plastics businesses delivers a broad range of technology-based products and solutions to customers in approximately 160 countries and in high growth sectors such as electronics, water, energy, coatings and agriculture. In 2011, Dow had annual sales of $60 billion and employed approximately 52,000 people worldwide. The Company's more than 5,000 products are manufactured at 197 sites in 36 countries across the globe. References to "Dow" or the "Company" mean The Dow Chemical Company and its consolidated subsidiaries unless otherwise expressly noted.

About OPX Biotechnologies

OPXBIO uses its proprietary leading EDGE™ (Efficiency Directed Genome Engineering) technology to manufacture renewable bio-based chemicals and fuels that provide more sustainable value than the existing petro-based products they will directly replace. With unprecedented speed and capital efficiency, in just 18 months OPXBIO has developed and piloted the microbe and bioprocess that will produce its first renewable chemical product - BioAcrylic. The company's second product is diesel fuel bio-processed from carbon dioxide and hydrogen. OPXBIO has raised $64 million with venture investors Altira Group, Braemar Energy Ventures, DBL Investors, Mohr Davidow Ventures, US Renewables Group, Wolfensohn Capital Partners, and X/Seed Capital.

About 3rd Biobased Chemicals Commercialization & Partnering Conference

This conference examines new supply chain developments and business models being adopted for bringing biobased chemicals products to market. Topics covered include novel chemical production platforms, advantageous feedstock, end user applications, securing funding and strategic partnerships, and the trends and challenges in commercial scale up. Development updates from renewable chemical companies, biofuel companies and end market consumers will be discussing innovations in the science, technology and end-market development of biobased chemicals, polymers and plastics.

Source: GTC Bio


Halcyon Group 3rd R&D Innovation Summit
Back to Top